RecruitingNot ApplicableNCT06474897

Comparison of Mobilization and Ozone Therapy in Impingement Syndrome

Comparison of the Efficacy of Mulligan Mobilization and Ozone Therapy in Patients With Subacromial Impingement Syndrome


Sponsor

Firat University

Enrollment

30 participants

Start Date

Jun 21, 2024

Study Type

INTERVENTIONAL

Summary

Studies investigating the efficacy of the Mulligan technique and ozone therapy in patients with shoulder impingement syndrome are limited in the literature. The aim of this study was to compare the effectiveness of Mulligan mobilization method and ozone therapy in patients with shoulder impingement syndrome. Ozone therapy will be practiced to study group. Mulligan mobilization will be practiced to control group. Pain, range of motion and function will be assessed before and after treatment.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria2

  • Patients aged 8-65 years
  • Patients with shoulder impingement syndrome

Exclusion Criteria6

  • Shoulder surgery
  • History of scoliosis
  • Infection
  • Cardiac pacemaker
  • Recent myocardial infarction
  • Malignancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEROzone therapy

Ozone therapy will be practiced to study group. Inject 10 ml of ozone gas (O2-O3) at a concentration of 10 µg/ml 3 times at one week intervals. All injections will be performed by the same experienced specialist doctor.

OTHERMulligan Mobilization

Mulligan mobilization will be practiced to control group. Mobilizations will be performed once a week for 3 consecutive weeks. The first one is a seated position with the patient's arm in approximately 90° abduction. The patient will be asked to abduct the arm and at the same time the physiotherapist will perform posterio/lateral gliding of the shoulder head with the left hand.


Locations(1)

Songul Baglan Yentur

Elâzığ, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06474897